FDA Adverse Event Malfunction Summary report: N

ACCUTREND PLUS GLUCOSE STRIPS

MDR report key: 10373563 · Received August 6, 2020

Report

Report Number
1823260-2020-01905
Event Type
Malfunction
Date Received
August 6, 2020
Date of Event
July 6, 2020
Report Date
August 6, 2020
Manufacturer
ROCHE DIAGNOSTICS
Product Code
CGA
PMA / PMN Number
K051376
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MX
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED IN (B)(6). THE CUSTOMER'S METERS AND STRIPS WERE REQUESTED FOR INVESTIGATION. THE PRODUCTS HAVE NOT BEEN RECEIVED AT THIS TIME. RETENTION SAMPLES FOR GLUCOSE LOT 349029-04 WERE MEASURED WITH RETENTION CONTROLS GKL60 LOT 346092-99 /GKL180 LOT 346093-99 AND 3 EDTA BLOOD ON REFERENCE DEVICES COMPARED TO LABORATORY METHOD. RANGES CONTROL SOLUTIONS: RANGE GKL 60: 58 ¿ 98 MG/DL. INVESTIGATION RESULTS USING RETENTION MATERIAL: QC 1: 78 MG/DL, QC 2: 74 MG/DL, QC 3: 72 MG/DL. INVESTIGATION RESULTS USING RETENTION MATERIAL: RANGE GKL 180: 166 ¿ 224 MG/DL, QC 1: 195 MG/DL, QC 2: 194 MG/DL, QC 3: 187 MG/DL. ALL RESULTS WERE WITHIN THE CONTROL RANGE. NO SIGNIFICANT DIFFERENCES TO THE LABORATORY METHOD. THE INVESTIGATION IS ONGOING.

Description of Event or Problem · 1

THE INITIAL REPORTER RECEIVED QUESTIONABLE GLUCOSE RESULTS USING AN ACCUTREND PLUS METER WHEN COMPARED TO AN ACCU-CHEK ACTIVE METER. THE METER RESULT ON THE ACCUTREND METER WAS 82 MG/DL. A FEW MINUTES LATER, THE CUSTOMER TESTED ON THE ACCU-CHEK ACTIVE METER. THE RESULT WAS 110 MG/DL. THE CUSTOMER PROVIDED TWO ACCUTREND METER SERIAL NUMBERS (B)(4). IT IS UNKNOWN WHICH METER GAVE THE RESULT. THE ACCU-CHEK ACTIVE METER'S SERIAL NUMBER WAS REQUESTED BUT NOT PROVIDED. IT IS NOT KNOWN WHICH RESULT WAS BELIEVED TO BE CORRECT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
838850 ACCUTREND PLUS GLUCOSE STRIPS BLOOD GLUCOSE MONITORING TEST STRIPS CGA ROCHE DIAGNOSTICS NA 34902904

Patients

Seq Age Sex Outcome Treatment
1